APA (7th ed.) Citation

Yujia Wang, Guoyu Wu, Ru Li, Yingzhe Luo, Xingmei Huang, Lifang He, . . . Shaoquan Xiong. (2021). Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yujia Wang, Guoyu Wu, Ru Li, Yingzhe Luo, Xingmei Huang, Lifang He, Huihui Zhong, and Shaoquan Xiong. Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Yujia Wang, et al. Chinese Medicine Combined With EGFR-TKIs Prolongs Progression-Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone. Frontiers Media S.A., 2021.